Melanoma is a type of skin cancer that develops from cells called melanocytes, is one of the fastest-growing and deadliest cancer in the world. It usually caused by DNA damage resulting from exposure to ultraviolet Read more…
Last week, HCS Pharma had the pleasure to attend to COSM’ING 2018 for their 20th anniversary which took place in the Palais du Grand Large at Saint Malo from the 4th to 6th July ! Read more…
In a recent article, Dr Antony Orth from the Australian Research Council’s, Centre of Excellence for Nanoscale BioPhotonics (CNBP) explains how to use the photobleaching phenomenon to increase the potential of fluorescence microscopy. The BAMM technique (bleaching-assisted Read more…
Last week we had the pleasure to attend the first SLAS Europe (Society for Laboratory Automation and Screening) meeting, which took place in the great Brussels Square meeting centre (Belgium) between the 27th and the Read more…
HCS pharma has organized its second scientific advisory board! We were pleased to gather around the table (physically or via a Webex visioconference for those who could not make the trip) David Devos, Roméo Cecchelli, Read more…
We are pleased to announce for our US customers that BIOMIMESYS® Hydroscaffold are available for direct sale at our distributor Iwai North America Inc. Thank you again for your previous orders and for your trust in HCS Read more…
Since the liver is responsible for the selective uptake, metabolism and excretion of xenobiotics, this organ is highly predisposed to drug-induced toxicity: this essential function is the primary reason for the failure of pharmaceuticals during Read more…
We are pleased to announce the launch of our new page dedicated to nutraceuticals! We have developed four assays to confirm the efficacy of nutraceuticals on human and animal cells. Our assays are based on Read more…
Meeting us at SLAS Europe 2018, on Wednesday 27th & Thursday 28th of June on Molecular Device Booth (#401) at the Square Brussels Meeting Centre, Brussels, Belgium.
We had the pleasure to attend ELRIG Fr meeting in Bischoffsheim (near Strasbourg) on the 23-24th of May. There we enjoyed meeting our partners Molecular Devices and Integra biosciences, and seeing great presentations about the Read more…
Researchers from the Department of Dermatology of the University of California have a commensal strain of Staphylococcus epidermidis that protects against skin neoplasia. This strain produces 6-N-hydroxyaminopurine (6-HAP), a molecule that inhibits DNA polymerase activity. Mice colonized with Read more…
Interesting paper from Christian Dani team about the potential of Brown and brown-like adipocytes (BAs) proginitors derived from hiPSCs to dissipate energy stored and the promising potential to treat obesity and metabolic disorder. In this Read more…
Thank to our partner Integra Biosciences, we are happy to present you an application note about a straightforward workflow for 3D cell seeding and spheroid formation using HCS Pharma’s BIOMIMESYS® plates in combination with INTEGRA’s VIAFLO 96/384 Read more…
As you should know, the GDPR (General Data Protection Regulation) is now a reality and every companies in Europe has to be “compliant” with it. Of course we’re updating our privacy policy (soon) but, in HCS Read more…
Last week, we attended to the 6th edition of COSMED Meeting in the west of France. We would like to thank the organisation team of COSMED for giving us the opportunity to attend to this event. Read more…
Our new poster on BIOMIMESYS® technology is now avalaible on this link. It presents the use of this scaffold on our automated platform (Hapix), with the development of a 3D cell model for steatosis and phospholipidosis Read more…
The first EUROoC meeting, dealing with organ-on-chip research and organized by the Chemical and Biological Microsystems Society (CBMS), will take place on the 24th-25th of May 2018 in Stuttgart (Germany). Interestingly, this new workshop will address the engineering challenges Read more…
As shown by AstraZeneca in Nature reviews*, one third of the safety failures is linked to CNS toxicity during the clinical trials of drugs. Therefore, relevant in vitro human model is needed to detect early Read more…
Farah has joined us for a four-month internship to explore the sector of agri-food market in the north of France. After a bachelor degree in cellular biology and physiology with a specialization in nutrition, Farah Read more…
Next week (the 23th and the 24th of May), we will be in Strasbourg to participate to ELRIGfr event, where we will present two posters. The first poster is about BIOMIMESYS® hydroscaffold for 3D cell culture and Read more…
Thanks a lot to the organization of In Cosmetics for this amazing event. In Cosmetics offered us a large diversity of matches including scientist and sales but also with our current partners. This year more Read more…
One third of the safety failures is linked to CNS toxicity during the clinical trials of drugs. In order to develop a more predictable in vitro human model for neurotoxicity testing, we have compared the Read more…
We are very happy to be present at In Cosmetics Amsterdam ! We are here to talk about our news services for in vitro testing in cosmetics. We also bring with us some BIOMIMESYS® samples, Read more…